Company profile

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to treat cancer and fibrosis

Industry
Pharmaceutical Manufacturing
Employees
36
Headquarters
Alderley Park, Macclesfield
Founded
2010
LinkedIn followers
12,632
Office locations
1

Redx Pharma company summary

Redx Pharma is a company in the Pharmaceutical Manufacturing industry, headquartered in Alderley Park, Macclesfield, founded in 2010. On LinkedIn the company has around 36 employees and 12,632 followers. Its listed specialties include Oncology, Fibrosis, Pharmaceuticals, Drug Discovery and Development, Biotech.

What technology does Redx Pharma use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Redx Pharma

Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for idiopathic pulmonary fibrosis and commenced a Phase 2 clinical trial in Q4 2022. Redx’s second ROCK inhibitor candidate, RXC008, a GI-targeted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn’s disease, commenced a Phase 1 clinical trial in Q1 2024. The Company's lead oncology product candidate, the Porcupine inhibitor, zamaporvint (RXC004), commenced a Phase 2 programme in November 2021. The Company has a strong track record of discovering new drug candidates through its core strengths in medicinal chemistry and translational science, enabling the Company to discover and develop differentiated therapeutics against biologically or clinically validated targets. Read more about our company at https://www.redxpharma.com/about-us/ If you're interested in joining us, please visit https://www.redxpharma.com to see what job vacancies we currently have.

Specialties

OncologyFibrosisPharmaceuticalsDrug Discovery and DevelopmentBiotech

Where is Redx Pharma located?

Redx Pharma lists 1 location.

Alderley Park, Macclesfield SK10 4TG, GBHQ
Block 33

Compare companies similar to Redx Pharma

More companies in Pharmaceutical Manufacturing.

CompanyIndustryEmployeesFoundedHeadquarters
Redx Pharma
redxpharma.com
Pharmaceutical Manufacturing362010Alderley Park, Macclesfield
Pharmaceutical Manufacturing108,102-New York, New York
Sanofi
sanofi.com
Pharmaceutical Manufacturing93,352-Paris, France, FR
GSK
gsk.com
Pharmaceutical Manufacturing92,179-London, England
Novartis España
novartis.com
Pharmaceutical Manufacturing85,373-Basel, Baselstadt
AstraZeneca
astrazeneca.com
Pharmaceutical Manufacturing80,667-Cambridge, Cambridgeshire, GB
Pharmaceutical Manufacturing57,202-Indianapolis, Indiana
Merck
merck.us
Pharmaceutical Manufacturing44,794-Rahway, New Jersey
SUN PHARMA
sunpharma.com
Pharmaceutical Manufacturing47,7641983Mumbai, Maharastra
Boehringer Ingelheim
boehringer-ingelheim.com
Pharmaceutical Manufacturing47,150-Ingelheim am Rhein, Rhineland-Palatinate
Cipla
cipla.com
Pharmaceutical Manufacturing51,911-Mumbai, Maharashtra

Frequently asked questions about Redx Pharma

What does Redx Pharma do?

Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for idiopathic pulmonary fibrosis and commenced a Phase 2 clinical trial in Q4 2022. Redx’s second ROCK inhibitor candidate, RXC008, a GI-targeted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn’s disease, commenced a Phase 1 clinical trial in Q1 2024. The Company's lead oncology product candidate, the Porcupine inhibitor, zamaporvint (RXC004), commenced a Phase 2 programme in November 2021. The Company has a strong track record of discovering new drug candidates through its core strengths in medicinal chemistry and translational science, enabling the Company to discover and develop differentiated therapeutics against biologically or clinically validated targets. Read more about our company at https://www.redxpharma.com/about-us/ If you're interested in joining us, please visit https://www.redxpharma.com to see what job vacancies we currently have.

How many employees does Redx Pharma have?

Redx Pharma has around 36 employees on LinkedIn.

Where is Redx Pharma headquartered?

Redx Pharma is headquartered in Alderley Park, Macclesfield.

When was Redx Pharma founded?

Redx Pharma was founded in 2010.

Build a lead list from companies like Redx Pharma

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.